Proniosomes derived niosomes: recent advancements in drug delivery and targeting

References

• Abd-Elbary A, El-Laithy H, Tadros M. (2008). Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm 357:189–98.
   PubMed Web of Science ®Google Scholar
• Abdelbary GA, Aburahma MH. (2015). Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain. J Liposome Res 25:107–21.
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Wu Z, Al-Kassas R, Alany RG. (2012). Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects. Int J Pharm 433:142–8.
   PubMed Web of Science ®Google Scholar
• Abdou EM, Ahmed NM. (2016). Terconazole proniosomal gels: effect of different formulation factors, physicochemical and microbiological evaluation. J Pharm Drug Deliv Res 5:1.
   Google Scholar
• Aburahma MH, Abdelbary GA. (2012). Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation. Int J Pharm 422:139–50.
   PubMed Web of Science ®Google Scholar
• Agrati C, Marianecci C, Sennato S, et al. (2011). Multicompartment vectors as novel drug delivery systems: selective activation of Tγδ lymphocytes after zoledronic acid delivery. Nanomed Nanotechnol Biol Med 7:153–61.
   PubMed Web of Science ®Google Scholar
• Ahmad MZ, Alkahtani SA, Akhter S, et al. (2016). Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art. J Drug Targeting 24:273–93.
   PubMed Web of Science ®Google Scholar
• Ahmad MZ, Mohammed AA, Mokhtar Ibrahim M. (2017). Technology overview and drug delivery application of proniosome. Pharm Dev Technol 22:302–11.
   PubMed Web of Science ®Google Scholar
• Akhilesh D, Faishal G, Kamath J. (2012). Comparative study of carriers used in proniosomes. Int J Pharm Chem Sci 3:6–12.
   Google Scholar
• Akhilesh D, Hazel G, Kamath J. (2011). Proniosomes–A propitious provesicular drug carrier. Int J Pharm Pharm Sci Res 1:98–103.
   Google Scholar
• Ali J, Ali M, Baboota S, et al. (2010). Potential of nanoparticulate drug delivery systems by intranasal administration. Curr Pharm Design 16:1644–53.
   PubMed Web of Science ®Google Scholar
• Ali J, Fazil M, Qumbar M, et al. (2016). Colloidal drug delivery system: amplify the ocular delivery. Drug Deliv 23:700–16.
   Web of Science ®Google Scholar
• Alsarra IA, Hamed AY, Alanazi FK, El Maghraby GM. (2010). Vesicular systems for intranasal drug delivery. In: Drug delivery to the central nervous system. New York: Springer, 175–203.
   Google Scholar
• Alukda D, Sturgis T, Youan BBC. (2011). Formulation of tenofovir‐loaded functionalized solid lipid nanoparticles intended for HIV prevention. J Pharm Sci 100:3345–56.
   PubMed Web of Science ®Google Scholar
• Ammar H, Ghorab M, EL-Nahhas S, Higazy I. (2011). Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm 405:142–52.
   PubMed Web of Science ®Google Scholar
• Bahadur S, Pathak K. (2012). Physicochemical and physiological considerations for efficient nose-to-brain targeting. Expert Opin Drug Deliv 9:19–31.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Onyuksel H. (2012). Peptide delivery using phospholipid micelles. Wires Nanomed Nanobiotechnol 4:562–74.
   PubMed Web of Science ®Google Scholar
• Bhatt R, Singh D, Prakash A, Mishra N. (2015). Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington’s disease. Drug Deliv 22:931–9.
   PubMed Web of Science ®Google Scholar
• Bochot A, Fattal E. (2012). Liposomes for intravitreal drug delivery: a state of the art. J Control Release 161:628–34.
   PubMed Web of Science ®Google Scholar
• Bolzinger MA, Briançon S, Chevalier Y. (2011). Nanoparticles through the skin: managing conflicting results of inorganic and organic particles in cosmetics and pharmaceutics. Wiley Interdiscip Rev 3:463–78.
   Google Scholar
• Bozdag S, Dillen K, Vandervoort J, Ludwig A. (2005). The effect of freeze‐drying with different cryoprotectants and gamma‐irradiation sterilization on the characteristics of ciprofloxacin HCl‐loaded poly (D, L‐lactide‐glycolide) nanoparticles. J Pharm Pharmacol 57:699–707.
   PubMed Web of Science ®Google Scholar
• Caddeo C, Pons R, Carbone C, et al. (2017). Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol. Carbohydr Polym 157:1853–61.
   PubMed Web of Science ®Google Scholar
• Chaw CS, Ah Kim KY. (2013). Effect of formulation compositions on niosomal preparations. Pharm Dev Technol 18:667–72.
   PubMed Web of Science ®Google Scholar
• Chen H, Chi X, Li B, et al. (2014a). Drug loaded multilayered gold nanorods for combined photothermal and chemotherapy. Biomater Sci 2:996–1006.
   Web of Science ®Google Scholar
• Chen H, Li B, Qiu J, et al. (2013). Thermal responsive micelles for dual tumor-targeting imaging and therapy. Nanoscale 5:12409–24.
   PubMed Web of Science ®Google Scholar
• Chen H, Li B, Zhang M, et al. (2014b). Characterization of tumor-targeting Ag2S quantum dots for cancer imaging and therapy in vivo. Nanoscale 6:12580–90.
   PubMed Web of Science ®Google Scholar
• Chopra K, Misra S, Kuhad A. (2011). Neurobiological aspects of Alzheimer's disease. Expert Opin Ther Targets 15:535–55.
   PubMed Web of Science ®Google Scholar
• Dai Y, Zhou R, Liu L, et al. (2013). Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation. Int J Nanomedicine 8:1921–33.
   PubMed Web of Science ®Google Scholar
• Das Neves J, Amiji M, Sarmento B. (2011). Mucoadhesive nanosystems for vaginal microbicide development: friend or foe? Wiley Interdiscip Rev Nanomed Nanobiotechnol 3:389–99.
   PubMed Web of Science ®Google Scholar
• Date AA, Shibata A, Goede M, et al. (2012). Development and evaluation of a thermosensitive vaginal gel containing raltegravir + efavirenz loaded nanoparticles for HIV prophylaxis. Antiviral Res 96:430–6.
   PubMed Web of Science ®Google Scholar
• De Araújo Pereira RR, Bruschi ML. (2012). Vaginal mucoadhesive drug delivery systems. Drug Dev Ind Pharm 38:643–52.
   PubMed Web of Science ®Google Scholar
• Dhangar R, Bhowmick M, Parihar SS, et al. (2014). Design and evaluation of proniosomes as drug carrier for ocular delivery of levofloxacin. J Drug Deliv Ther 4:182–9.
   Google Scholar
• Din FU, Choi JY, Kim DW, et al. (2017). Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration. Drug Deliv 24:502–10.
   PubMed Web of Science ®Google Scholar
• El-Alim SA, Kassem A, Basha M. (2014). Proniosomes as a novel drug carrier system for buccal delivery of benzocaine. J Drug Deliv Sci Technol 24:452–8.
   Web of Science ®Google Scholar
• El-Laithy HM, Shoukry O, Mahran LG. (2011). Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm 77:43–55.
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Ahmed AA, Osman MA. (2015). Penetration enhancers in proniosomes as a new strategy for enhanced transdermal drug delivery. Saudi Pharm J 23:67–74.
   PubMed Web of Science ®Google Scholar
• El Maghraby GM, Barry BW, Williams AC. (2008). Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 34:203–22.
   PubMed Web of Science ®Google Scholar
• Elhissi A, Hidayat K, Phoenix DA, et al. (2013). Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology. Int J Pharm 444:193–9.
   PubMed Web of Science ®Google Scholar
• Ensign LM, Cone R, Hanes J. (2014). Nanoparticle-based drug delivery to the vagina: a review. J Control Release 190:500–14.
   PubMed Web of Science ®Google Scholar
• Fang JY, Yu SY, Wu PC, et al. (2001). In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 215:91–9.
   PubMed Web of Science ®Google Scholar
• Fei WL, Chen JQ, Yuan J, et al. (2008). Preliminary study of the effect of FK506 nanospheric-suspension eye drops on rejection of penetrating keratoplasty. J Ocular Pharmacol Ther 24:235–44.
   PubMed Web of Science ®Google Scholar
• Fukushima K, Ise A, Morita H, et al. (2011). Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats. Pharm Res 28:7–21.
   PubMed Web of Science ®Google Scholar
• Furst T, Piette M, Lechanteur A, et al. (2015). Mucoadhesive cellulosic derivative sponges as drug delivery system for vaginal application. Eur J Pharm Biopharm 95:128–35.
   PubMed Web of Science ®Google Scholar
• Gad HA, Kamel AO, Sammour OA, El Dessouky HF. (2014). Vesicular powder as carrier for doxycycline hydrochloride and metronidazole combination therapy. Pharm Dev Technol 19:755–68.
   PubMed Web of Science ®Google Scholar
• Garg V, Jain GK, Nirmal J, Kohli K. (2013). Topical tacrolimus nanoemulsion, a promising therapeutic approach for uveitis. Med Hypotheses 81:901–4.
   PubMed Web of Science ®Google Scholar
• Grabovac V, Guggi D, Bernkop-Schnürch A. (2005). Comparison of the mucoadhesive properties of various polymers. Adv Drug Deliv Rev 57:1713–23.
   PubMed Web of Science ®Google Scholar
• Gupta H, Aqil M, Khar R, et al. (2015). An alternative in situ gel-formulation of levofloxacin eye drops for prolong ocular retention. J Pharm Bioall Sci 7:9.
   PubMed Web of Science ®Google Scholar
• Gupta H, Babu R. (2013). Transdermal delivery: product and patent update. DDF 7:184–205.
   Google Scholar
• Gurrapu A, Jukanti R, Bobbala SR, et al. (2012). Improved oral delivery of valsartan from maltodextrin based proniosome powders. Adv Powder Technol 23:583–90.
   Web of Science ®Google Scholar
• Hainer BL, Gibson MV. (2011). Vaginitis: diagnosis and treatment. Am Fam Physician 83:807–15.
   PubMed Web of Science ®Google Scholar
• Hearnden V, Sankar V, Hull K, et al. (2012). New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Adv Drug Deliv Rev 64:16–28.
   PubMed Web of Science ®Google Scholar
• Hofland H, Bouwstra J, Verhoef J, et al. (1992). Safety aspects of non‐ionic surfactant vesicles: a toxicity study related to the physicochemical characteristics of non‐ionic surfactants. J Pharm Pharmacol 44:287–94.
   PubMed Web of Science ®Google Scholar
• Hu C, Rhodes DG. (1999). Proniosomes: a novel drug carrier preparation. Int J Pharm 185:23–35.
   PubMed Web of Science ®Google Scholar
• Hua S, Wu SY. (2013). The use of lipid-based nanocarriers for targeted pain therapies. Front Pharmacol 4:143.
   PubMed Web of Science ®Google Scholar
• Imam SS, Aqil M, Akhtar M, et al. (2015). Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study. Drug Deliv 22:1059–70.
   PubMed Web of Science ®Google Scholar
• Janga KY, Jukanti R, Velpula A, et al. (2012). Bioavailability enhancement of zaleplon via proliposomes: role of surface charge. Eur J Pharm Biopharm 80:347–57.
   PubMed Web of Science ®Google Scholar
• Kamboj S, Saini V, Maggon N, et al. (2013). Novel vesicular drug carriers for bioavailability enhancement. Int J Pharm Sci Rev Res 22:92–7.
   Google Scholar
• Kamel R, Basha M, Abd El-Alim SH. (2013). Development of a novel vesicular system using a binary mixture of sorbitan monostearate and polyethylene glycol fatty acid esters for rectal delivery of rutin. J Liposome Res 23:28–36.
   PubMed Web of Science ®Google Scholar
• Katare OP, Raza K, Singh B, Dogra S. (2010). Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors. Indian J Dermatol Venereol Leprol 76:612.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Rana C, Singh M, et al. (2012). Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole. J Ocular Pharmacol Ther 28:484–96.
   PubMed Web of Science ®Google Scholar
• Khade S, Behera B, Sagiri S, et al. (2014). Gelatin–PEG based metronidazole-loaded vaginal delivery systems: preparation, characterization and in vitro antimicrobial efficiency. Iran Polym J 23:171–84.
   Web of Science ®Google Scholar
• Khalil RM, Abdelbary GA, Basha M, et al. (2016). Design and evaluation of proniosomes as a carrier for ocular delivery of lomefloxacin HCl. J Liposome Res 27:1–12.
   PubMed Web of Science ®Google Scholar
• Khan MI, Madni A, Peltonen L. (2016). Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. Eur J Pharm Sci 95:88–95.
   PubMed Web of Science ®Google Scholar
• Komal R, Mahendra G, Shivraj P, Vinod A. (2013). Novel trends in parenteral drug delivery system: review. Int J Pharm Technol 5:2549–77.
   Google Scholar
• Kraft JC, Freeling JP, Wang Z, Ho RJ. (2014). Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J Pharm Sci 103:29–52.
   PubMed Web of Science ®Google Scholar
• Kumar K, Rai A. (2012). Proniosomal formulation of curcumin having anti-inflammatory and anti-arthritic activity in different experimental animal models. Pharmazie Int J Pharm Sci 67:852–7.
   Google Scholar
• Kuzmov A, Minko T. (2015). Nanotechnology approaches for inhalation treatment of lung diseases. J Control Release 219:500–18.
   PubMed Web of Science ®Google Scholar
• Li Q, Li Z, Zeng W, et al. (2014). Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. Eur J Pharm Sci 62:115–23.
   PubMed Web of Science ®Google Scholar
• Luo Q, Zhao J, Zhang X, Pan W. (2011). Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm 403:185–91.
   PubMed Web of Science ®Google Scholar
• Luschmann C, Tessmar J, Schoeberl S, et al. (2013). Developing an in situ nanosuspension: a novel approach towards the efficient administration of poorly soluble drugs at the anterior eye. Eur J Pharm Sci 50:385–92.
   PubMed Web of Science ®Google Scholar
• Madan JR, Ghuge NP, Dua K. (2016). Formulation and evaluation of proniosomes containing lornoxicam. Drug Deliv Translat Res 6:511–18.
   PubMed Web of Science ®Google Scholar
• Mahale N, Thakkar P, Mali R, et al. (2012). Niosomes: novel sustained release nonionic stable vesicular systems—an overview. Adv Colloid Interface Sci 183:46–54.
   PubMed Web of Science ®Google Scholar
• Maiti S, Paul S, Mondol R, et al. (2011). Nanovesicular formulation of brimonidine tartrate for the management of glaucoma: in vitro and in vivo evaluation. AAPS PharmSciTech 12:755–63.
   PubMed Web of Science ®Google Scholar
• Mak WC, Richter H, Patzelt A, et al. (2011). Drug delivery into the skin by degradable particles. Eur J Pharm Biopharm 79:23–7.
   PubMed Web of Science ®Google Scholar
• Marianecci C, Di Marzio L, Rinaldi F, et al. (2014). Niosomes from 80s to present: the state of the art. Adv Colloid Interface Sci 205:187–206.
   PubMed Web of Science ®Google Scholar
• Marianecci C, Rinaldi F, Esposito S, et al. (2013). Niosomes encapsulating ibuprofen–cyclodextrin complexes: preparation and characterization. CDT 14:1070–8.
   Google Scholar
• Maurer JK, Li HF, Petroll WM, et al. (1997). Confocal microscopic characterization of initial corneal changes of surfactant-induced eye irritation in the rabbit. Toxicol Appl Pharmacol 143:291–300.
   PubMed Web of Science ®Google Scholar
• Maurer JK, Parker RD, Carr GJ. (1998). Ocular irritation: microscopic changes occurring over time in the rat with surfactants of known irritancy. Toxicol Pathol 26:217–25.
   PubMed Web of Science ®Google Scholar
• Mehta M, Dureja H, Garg M. (2016). Development and optimization of boswellic acid-loaded proniosomal gel. Drug Deliv 23:3072–81.
   PubMed Web of Science ®Google Scholar
• Meng J, Sturgis TF, Youan B-BC. (2011). Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion. Eur J Pharm Sci 44:57–67.
   PubMed Web of Science ®Google Scholar
• Mir M, Ishtiaq S, Rabia S, et al. (2017). Nanotechnology: from in vivo imaging system to controlled drug delivery. Nanoscale Res Lett 12:500.
   PubMed Web of Science ®Google Scholar
• Misra A, Hickey AJ, Rossi C, et al. (2011). Inhaled drug therapy for treatment of tuberculosis. Tuberculosis 91:71–81.
   PubMed Web of Science ®Google Scholar
• Mujoriya RZ, Bodla R. (2011). Niosomes–challenge in preparation for pharmaceutical scientist. Int J App Pharm 3:11–15.
   Google Scholar
• Mustapha O, Din FU, Kim DW, et al. (2016). Novel piroxicam-loaded nanospheres generated by the electrospraying technique: physicochemical characterisation and oral bioavailability evaluation. J Microencapsul 33:323–30.
   PubMed Web of Science ®Google Scholar
• Muzzalupo R. (2016). Niosomes and proniosomes for enhanced skin delivery. In: Percutaneous penetration enhancer’s chemical methods in penetration enhancement. New York: Springer, 147–60.
   Google Scholar
• Nagarwal RC, Kumar R, Pandit J. (2012). Chitosan coated sodium alginate–chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye. Eur J Pharm Sci 47:678–85.
   PubMed Web of Science ®Google Scholar
• Nahar K, Gupta N, Gauvin R, et al. (2013). In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals. Eur J Pharm Sci 49:805–18.
   PubMed Web of Science ®Google Scholar
• Najlah M, Hidayat K, Omer HK, et al. (2015). A facile approach to manufacturing non-ionic surfactant nanodipsersions using proniosome technology and high-pressure homogenization. J Liposome Res 25:32–7.
   PubMed Web of Science ®Google Scholar
• Nasr M. (2010). In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration. AAPS PharmSciTech 11:85–9.
   PubMed Web of Science ®Google Scholar
• Neves JD, Palmeira-de-Oliveira R, Palmeira-De-Oliveira A, et al. (2014). Vaginal mucosa and drug delivery. In: Mucoadhesive materials and drug delivery systems. Chichester: Wiley, 99–132.
   Google Scholar
• Ning M, Guo Y, Pan H, et al. (2005). Niosomes with sorbitan monoester as a carrier for vaginal delivery of insulin: studies in rats. Drug Deliv 12:399–407.
   PubMed Web of Science ®Google Scholar
• Paecharoenchai O, Teng L, Yung BC, et al. (2013). Nonionic surfactant vesicles for delivery of RNAi therapeutics. Nanomedicine (Lond) 8:1865–73.
   PubMed Web of Science ®Google Scholar
• Pathan IB, Setty CM. (2009). Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res 8:2.
   Web of Science ®Google Scholar
• Pham TT, Jaafar-Maalej C, Charcosset C, Fessi H. (2012). Liposome and niosome preparation using a membrane contactor for scale-up. Colloids Surf B 94:15–21.
   PubMed Web of Science ®Google Scholar
• Rahman SA, Abdelmalak NS, Badawi A, et al. (2015). Formulation of tretinoin-loaded topical proniosomes for treatment of acne: in-vitro characterization, skin irritation test and comparative clinical study. Drug Deliv 22:731–9.
   PubMed Web of Science ®Google Scholar
• Rajabalaya R, Leen G, Chellian J, et al. (2016). Tolterodine tartrate proniosomal gel transdermal delivery for overactive bladder. Pharmaceutics 8:27.
   Web of Science ®Google Scholar
• Rajera R, Nagpal K, Singh SK, Mishra DN. (2011). Niosomes: a controlled and novel drug delivery system. Biol Pharm Bull 34:945–53.
   PubMed Web of Science ®Google Scholar
• Ramesh YV, Jawahar N, Jakki SL. (2013). Proniosomes: a novel nano vesicular transdermal drug delivery. J Pharm Sci Res 5:153–8.
   Google Scholar
• Rashid R, Kim DW, Abid Mehmood Yousaf OM, et al. (2015a). Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe. Int J Nanomedicine 10:6147.
   PubMed Web of Science ®Google Scholar
• Rashid R, Kim DW, Ud Din F, et al. (2015b). Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion. Carbohydr Polym 130:26–31.
   PubMed Web of Science ®Google Scholar
• Ruckmani K, Sankar V, Sivakumar M. (2010). Tissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomes. J Biomed Nanotechnol 6:43–51.
   PubMed Web of Science ®Google Scholar
• Sahoo RK, Biswas N, Guha A, Kuotsu K. (2014). Maltodextrin based proniosomes of nateglinide: bioavailability assessment. Int J Biol Macromol 69:430–4.
   PubMed Web of Science ®Google Scholar
• Sankar V, Hearnden V, Hull K, et al. (2011). Local drug delivery for oral mucosal diseases: challenges and opportunities. Oral Dis 17:73–84.
   PubMed Web of Science ®Google Scholar
• Santos SS, Lorenzoni A, Ferreira LM, et al. (2013). Clotrimazole-loaded Eudragit® RS100 nanocapsules: preparation, characterization and in vitro evaluation of antifungal activity against Candida species. Mater Sci Eng C 33:1389–94.
   PubMed Web of Science ®Google Scholar
• Santos T, Maia J, Agasse F, et al. (2012). Nanomedicine boosts neurogenesis: new strategies for brain repair. Integr Biol 4:973–81.
   Google Scholar
• Shaker DS, Nasr M, Mostafa M. (2013). Bioavailability and hypocholesterolemic effect of proniosomal simvastatin for transdermal delivery. Int J Pharm Pharm Sci 5:344–51.
   Google Scholar
• Shehata TM, Abdallah MH, Ibrahim MM. (2015). Proniosomal oral tablets for controlled delivery and enhanced pharmacokinetic properties of acemetacin. AAPS PharmSciTech 16:375–83.
   PubMed Web of Science ®Google Scholar
• Shukr MH, Eltablawy NA. (2015). Development and optimization of novel controlled-release pioglitazone provesicular powders using 32 factorial design. Drug Deliv and Transl Res 5:51–62.
   PubMed Web of Science ®Google Scholar
• Soliman SM, Abdelmalak NS, El-Gazayerly ON, Abdelaziz N. (2016). Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 23 factorial design and in vivo evaluation in rabbits. Drug Deliv 23:1608–22.
   PubMed Web of Science ®Google Scholar
• Song S, Tian B, Chen F, et al. (2015). Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs. Drug Dev Ind Pharm 41:51–62.
   PubMed Web of Science ®Google Scholar
• Todoroff J, Vanbever R. (2011). Fate of nanomedicines in the lungs. Curr Opin Colloid Interface Sci 16:246–54.
   Web of Science ®Google Scholar
• Tu Y, Sun D, Zhang J, et al. (2014). Preparation and characterisation of andrographolide niosomes and its anti-hepatocellular carcinoma activity. J Microencapsulation 31:307–16.
   PubMed Web of Science ®Google Scholar
• Ud Din F, Kim DW, Choi JY, et al. (2017). Irinotecan-loaded double-reversible thermogel with improved antitumor efficacy without initial burst effect and toxicity for intramuscular administration. Acta Biomater 54:239–48.
   PubMed Web of Science ®Google Scholar
• Ud Din F, Mustapha O, Kim DW, et al. (2015a). Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect. Eur J Pharm Biopharm 94:64–72.
   PubMed Web of Science ®Google Scholar
• Ud Din F, Rashid R, Mustaph a, O, et al. (2015b). Development of a novel solid lipid nanoparticles-loaded dual-reverse thermosensitive nanomicelle for intramuscular administration with sustained release and reduced toxicity. RSC Adv 5:43687–94.
   Web of Science ®Google Scholar
• Vanić Ž, Hurler J, Ferderber K, et al. (2014). Novel vaginal drug delivery system: deformable propylene glycol liposomes-in-hydrogel. J Liposome Res 24:27–36.
   PubMed Web of Science ®Google Scholar
• Vanić Ž, Škalko-Basnet N. (2013). Nanopharmaceuticals for improved topical vaginal therapy: can they deliver? Eur J Pharm Sci 50:29–41.
   PubMed Web of Science ®Google Scholar
• Veerareddy PR, Bobbala SKR. (2013). Enhanced oral bioavailability of isradipine via proniosomal systems. Drug Dev Ind Pharm 39:909–17.
   PubMed Web of Science ®Google Scholar
• Verma P, Prajapati SK, Yadav R, et al. (2016). Single intravenous dose of novel flurbiprofen-loaded proniosome formulations provides prolonged systemic exposure and anti-inflammatory effect. Mol Pharm 13:3688–99.
   PubMed Web of Science ®Google Scholar
• Walve J, Rane B, Gujrathi N, et al. (2011). Proniosomes: a surrogated carrier for improved transdermal drug delivery system. Int J Res Ayurveda Pharm 2:743–50.
   Google Scholar
• Wen MM, Farid RM, Kassem AA. (2014). Nano-proniosomes enhancing the transdermal delivery of mefenamic acid. J Liposome Res 24:280–9.
   PubMed Web of Science ®Google Scholar
• Wohlrab J, Kreft B, Tamke B. (2011). Skin tolerability of transdermal patches. Expert Opin Drug Deliv 8:939–48.
   PubMed Web of Science ®Google Scholar
• Yadav JD, Kulkarni PR, Vaidya KA, Shelke GT. (2011). Niosomes: a review. J Pharm Res 4:632–6.
   Google Scholar
• Yang S, Chen Y, Ahmadie R, Ho EA. (2013). Advancements in the field of intravaginal siRNA delivery. J Control Release 167:29–39.
   PubMed Web of Science ®Google Scholar
• Yasam VR, Jakki SL, Natarajan J, Kuppusamy G. (2014). A review on novel vesicular drug delivery: proniosomes. Drug Deliv 21:243–9.
   PubMed Web of Science ®Google Scholar
• Yuksel N, Bayindir ZS, Aksakal E, Ozcelikay AT. (2016). In situ niosome forming maltodextrin proniosomes of candesartan cilexetil: in vitro and in vivo evaluations. Int J Biol Macromol 82:453–63.
   PubMed Web of Science ®Google Scholar
• Zaki Ahmad M, Akhter S, Mohsin N, et al. (2014). Transformation of curcumin from food additive to multifunctional medicine: nanotechnology bridging the gap. CDDT 11:197–213.
   Google Scholar
• Zhou QT, Tang P, Leung SSY, et al. (2014). Emerging inhalation aerosol devices and strategies: where are we headed? Adv Drug Deliv Rev 75:3–17.
   PubMed Web of Science ®Google Scholar
• Zidan AS, Mokhtar M. (2011). Multivariate optimization of formulation variables influencing flurbiprofen proniosomes characteristics. J Pharm Sci 100:2212–21.
   PubMed Web of Science ®Google Scholar